213 related articles for article (PubMed ID: 21695165)
1. Serum 25-hydroxyvitamin D and risk of lung cancer in male smokers: a nested case-control study.
Weinstein SJ; Yu K; Horst RL; Parisi D; Virtamo J; Albanes D
PLoS One; 2011; 6(6):e20796. PubMed ID: 21695165
[TBL] [Abstract][Full Text] [Related]
2. Serum vitamin D concentration and prostate cancer risk: a nested case-control study.
Ahn J; Peters U; Albanes D; Purdue MP; Abnet CC; Chatterjee N; Horst RL; Hollis BW; Huang WY; Shikany JM; Hayes RB;
J Natl Cancer Inst; 2008 Jun; 100(11):796-804. PubMed ID: 18505967
[TBL] [Abstract][Full Text] [Related]
3. Serum vitamin D and risk of bladder cancer.
Mondul AM; Weinstein SJ; Männistö S; Snyder K; Horst RL; Virtamo J; Albanes D
Cancer Res; 2010 Nov; 70(22):9218-23. PubMed ID: 20978193
[TBL] [Abstract][Full Text] [Related]
4. Serum 25-hydroxyvitamin D and risks of colon and rectal cancer in Finnish men.
Weinstein SJ; Yu K; Horst RL; Ashby J; Virtamo J; Albanes D
Am J Epidemiol; 2011 Mar; 173(5):499-508. PubMed ID: 21248311
[TBL] [Abstract][Full Text] [Related]
5. Association of 25-Hydroxyvitamin D with Liver Cancer Incidence and Chronic Liver Disease Mortality in Finnish Male Smokers of the ATBC Study.
Lai GY; Wang JB; Weinstein SJ; Parisi D; Horst RL; McGlynn KA; Männistö S; Albanes D; Freedman ND
Cancer Epidemiol Biomarkers Prev; 2018 Sep; 27(9):1075-1082. PubMed ID: 29720370
[No Abstract] [Full Text] [Related]
6. Serum 25-hydroxyvitamin D and risk of oropharynx and larynx cancers in Finnish men.
Arem H; Weinstein SJ; Horst RL; Virtamo J; Yu K; Albanes D; Abnet CC
Cancer Epidemiol Biomarkers Prev; 2011 Jun; 20(6):1178-84. PubMed ID: 21527582
[TBL] [Abstract][Full Text] [Related]
7. A prospective nested case-control study of vitamin D status and pancreatic cancer risk in male smokers.
Stolzenberg-Solomon RZ; Vieth R; Azad A; Pietinen P; Taylor PR; Virtamo J; Albanes D
Cancer Res; 2006 Oct; 66(20):10213-9. PubMed ID: 17047087
[TBL] [Abstract][Full Text] [Related]
8. Serum 25-hydroxy vitamin D and prostate cancer risk in a large nested case-control study.
Albanes D; Mondul AM; Yu K; Parisi D; Horst RL; Virtamo J; Weinstein SJ
Cancer Epidemiol Biomarkers Prev; 2011 Sep; 20(9):1850-60. PubMed ID: 21784952
[TBL] [Abstract][Full Text] [Related]
9. Impact of circulating vitamin D binding protein levels on the association between 25-hydroxyvitamin D and pancreatic cancer risk: a nested case-control study.
Weinstein SJ; Stolzenberg-Solomon RZ; Kopp W; Rager H; Virtamo J; Albanes D
Cancer Res; 2012 Mar; 72(5):1190-8. PubMed ID: 22232734
[TBL] [Abstract][Full Text] [Related]
10. Serum vitamin D, vitamin D binding protein, and risk of colorectal cancer.
Anic GM; Weinstein SJ; Mondul AM; Männistö S; Albanes D
PLoS One; 2014; 9(7):e102966. PubMed ID: 25036524
[TBL] [Abstract][Full Text] [Related]
11. Serum 25-hydroxyvitamin D concentrations and lung cancer risk in never-smoking postmenopausal women.
Cheng TD; Song X; Beresford SAA; Ho GYF; Johnson KC; Datta M; Chlebowski RT; Wactawski-Wende J; Qi L; Neuhouser ML
Cancer Causes Control; 2017 Oct; 28(10):1053-1063. PubMed ID: 28900765
[TBL] [Abstract][Full Text] [Related]
12. Serum vitamin D, vitamin D binding protein, and lung cancer survival.
Anic GM; Weinstein SJ; Mondul AM; Männistö S; Albanes D
Lung Cancer; 2014 Dec; 86(3):297-303. PubMed ID: 25456734
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D-binding protein and pancreatic cancer: a nested case-control study.
Piper MR; Freedman DM; Robien K; Kopp W; Rager H; Horst RL; Stolzenberg-Solomon RZ
Am J Clin Nutr; 2015 Jun; 101(6):1206-15. PubMed ID: 25904602
[TBL] [Abstract][Full Text] [Related]
14. Serum 25-hydroxyvitamin D, vitamin D binding protein and risk of colorectal cancer in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.
Weinstein SJ; Purdue MP; Smith-Warner SA; Mondul AM; Black A; Ahn J; Huang WY; Horst RL; Kopp W; Rager H; Ziegler RG; Albanes D
Int J Cancer; 2015 Mar; 136(6):E654-64. PubMed ID: 25156182
[TBL] [Abstract][Full Text] [Related]
15. Circulating levels of 25-hydroxyvitamin D and risk of breast cancer: a nested case-control study.
Scarmo S; Afanasyeva Y; Lenner P; Koenig KL; Horst RL; Clendenen TV; Arslan AA; Chen Y; Hallmans G; Lundin E; Rinaldi S; Toniolo P; Shore RE; Zeleniuch-Jacquotte A
Breast Cancer Res; 2013 Feb; 15(1):R15. PubMed ID: 23442740
[TBL] [Abstract][Full Text] [Related]
16. A prospective investigation of serum 25-hydroxyvitamin D and risk of lymphoid cancers.
Lim U; Freedman DM; Hollis BW; Horst RL; Purdue MP; Chatterjee N; Weinstein SJ; Morton LM; Schatzkin A; Virtamo J; Linet MS; Hartge P; Albanes D
Int J Cancer; 2009 Feb; 124(4):979-86. PubMed ID: 19035445
[TBL] [Abstract][Full Text] [Related]
17. A higher circulating concentration of 25-hydroxyvitamin-D decreases the risk of renal cell carcinoma: a case-control study.
Li F; Zhao H; Hou L; Ling F; Zhang Y; Tan W
Int Braz J Urol; 2019; 45(3):523-530. PubMed ID: 30785699
[TBL] [Abstract][Full Text] [Related]
18. Circulating Vitamin D and Colorectal Cancer Risk: An International Pooling Project of 17 Cohorts.
McCullough ML; Zoltick ES; Weinstein SJ; Fedirko V; Wang M; Cook NR; Eliassen AH; Zeleniuch-Jacquotte A; Agnoli C; Albanes D; Barnett MJ; Buring JE; Campbell PT; Clendenen TV; Freedman ND; Gapstur SM; Giovannucci EL; Goodman GG; Haiman CA; Ho GYF; Horst RL; Hou T; Huang WY; Jenab M; Jones ME; Joshu CE; Krogh V; Lee IM; Lee JE; Männistö S; Le Marchand L; Mondul AM; Neuhouser ML; Platz EA; Purdue MP; Riboli E; Robsahm TE; Rohan TE; Sasazuki S; Schoemaker MJ; Sieri S; Stampfer MJ; Swerdlow AJ; Thomson CA; Tretli S; Tsugane S; Ursin G; Visvanathan K; White KK; Wu K; Yaun SS; Zhang X; Willett WC; Gail MH; Ziegler RG; Smith-Warner SA
J Natl Cancer Inst; 2019 Feb; 111(2):158-169. PubMed ID: 29912394
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D-binding protein, circulating vitamin D and risk of renal cell carcinoma.
Mondul AM; Weinstein SJ; Moy KA; Männistö S; Albanes D
Int J Cancer; 2014 Jun; 134(11):2699-706. PubMed ID: 24214881
[TBL] [Abstract][Full Text] [Related]
20. No association between circulating concentrations of vitamin D and risk of lung cancer: an analysis in 20 prospective studies in the Lung Cancer Cohort Consortium (LC3).
Muller DC; Hodge AM; Fanidi A; Albanes D; Mai XM; Shu XO; Weinstein SJ; Larose TL; Zhang X; Han J; Stampfer MJ; Smith-Warner SA; Ma J; Gaziano JM; Sesso HD; Stevens VL; McCullough ML; Layne TM; Prentice R; Pettinger M; Thomson CA; Zheng W; Gao YT; Rothman N; Xiang YB; Cai H; Wang R; Yuan JM; Koh WP; Butler LM; Cai Q; Blot WJ; Wu J; Ueland PM; Midttun Ø; Langhammer A; Hveem K; Johansson M; Hultdin J; Grankvist K; Arslan AA; Le Marchand L; Severi G; Johansson M; Brennan P
Ann Oncol; 2018 Jun; 29(6):1468-1475. PubMed ID: 29617726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
